Related Experiment Video
Updated: May 23, 2025

A Method for Measuring RNA N6-methyladenosine Modifications in Cells and Tissues
Published on: December 5, 2016
Expression profile and N6-methyadenosine modification of circular RNA analysis in MAFLD
Mengyao Zheng1, Dongyun Cun2, Haiyu He1
1Department of Gastroenterology, The Second Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, 650101, China.
Background:
To analyze the expression patterns of circRNAs in metabolic associated fatty liver disease (MAFLD) and the regulation of m6A methylation on those circRNAs.
Methods:
The expression profile of CircRNA in MAFLD and normal control liver tissues was analyzed by microarray. Predict the potential m6A sites of the differentially expression circRNAs (DECs) via the SRAMP website. The biological functions and molecular interactions of DECs were analyzed by GO and KEGG analyses. The selected DECs were verified by MeRIP-qPCR and RT-qPCR.
Results:
There were 59 DECs in MAFLD liver tissues compared with normal control liver tissues. We found that m6A sites with high or very high confidence were present in 39 of these DECs. Four randomly selected DECs were validated by RT-qPCR, hsa-MLIP_0004, hsa-CHD2_0084 and hsa-FOXP1_0001 matched well with the microarray results. m6A qualification of them were conducted by MeRIP-qPCR, the m6A methylation levels are significantly different between the MAFLD and NC groups.
Conclusion:
In MAFLD, the dysregulated expression of circRNAs may be influenced by m6A modifications. This study provides preliminary evidence suggesting that m6A-mediated regulation of circRNAs could play a role in the progression of MAFLD, laying the foundation for exploring the epigenetic regulation of circRNAs in MAFLD and offering potential avenues for future diagnostic and therapeutic strategies.
Trial Registration:
Not applicable.
Insights
This study reveals that N6-methyladenosine (m6A) modification influences circular RNA (circRNA) expression in metabolic associated fatty liver disease (MAFLD). These findings suggest m6A-regulated circRNAs may drive MAFLD progression, offering new therapeutic targets.
Area of Science:
- Molecular Biology
- Epigenetics
- Hepatology
Background:
- Metabolic associated fatty liver disease (MAFLD) is a growing health concern.
- Circular RNAs (circRNAs) are increasingly recognized for their roles in various diseases.
- The role of m6A methylation in MAFLD-associated circRNA dysregulation remains unclear.
Purpose of the Study:
- To investigate the expression patterns of circRNAs in MAFLD.
- To explore the regulatory role of m6A methylation on circRNAs in MAFLD.
- To identify potential diagnostic and therapeutic targets for MAFLD.
Main Methods:
- Microarray analysis of circRNA expression in MAFLD and control liver tissues.
- Prediction of m6A sites on differentially expressed circRNAs (DECs) using SRAMP.
- Gene Ontology (GO) and KEGG pathway analyses for functional annotation of DECs.
- Validation of DECs and m6A modification levels by RT-qPCR and MeRIP-qPCR.
Main Results:
- 59 DECs were identified in MAFLD liver tissues compared to controls.
- m6A sites were predicted in 39 of the identified DECs.
- RT-qPCR validated the expression of selected DECs (hsa-MLIP_0004, hsa-CHD2_0084, hsa-FOXP1_0001).
- MeRIP-qPCR demonstrated significantly different m6A methylation levels in MAFLD versus control groups.
Conclusions:
- Dysregulated circRNA expression in MAFLD may be influenced by m6A modifications.
- m6A-mediated regulation of circRNAs is implicated in MAFLD progression.
- This study provides a foundation for understanding epigenetic regulation of circRNAs in MAFLD and developing novel strategies.
Related Concept Videos
MicroRNAs
RNA Stability
lncRNA - Long Non-coding RNAs
RNA Editing
Ribosome Profiling
Applications of ribosome profiling
Ribosome profiling has many applications, including in vivo monitoring of translation inside a particular organ or tissue type and quantifying new protein synthesis levels.
The technique...
Master Transcription Regulators

